Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues [PDF]
Neuroendocrine breast tumors represent a rare subtype of breast cancer, accounting for less than 1% of all neuroendocrine neoplasms. Starting from their pathology definition, and going through their prevalence, prognosis and treatment, our knowledge is ...
Marco Gallo +9 more
doaj +5 more sources
Evaluation of diagnostic efficacy of multimode ultrasound in BI-RADS 4 breast neoplasms and establishment of a predictive model [PDF]
ObjectivesTo explore the diagnostic efficacy of ultrasound (US), two-dimensional and three-dimensional shear-wave elastography (2D-SWE and 3D-SWE), and contrast-enhanced ultrasound (CEUS) in breast neoplasms in category 4 based on the Breast Imaging ...
Yunhao Chen +5 more
doaj +3 more sources
Metastatic Neoplasms to the Breast
Objective When the clinical presentation is related to the metastatic mass and a radiologically solitary tumor focus is detected, especially in cases where clinical information is not taken into account or is insufficient, if a possible metastatic neoplasia is not kept in mind then it is possible to evaluate the
Mine Özşen +4 more
openaire +4 more sources
Phyllodes tumor of the breast. Clinical case
Rare breast neoplasms are found by physicians in clinical practice. Phyllodes tumor of the breast accounting for 0.3–1% of all breast neoplasms is one of these neoplasms. Today, the phyllodes tumor etiology is unclear, the same as its pathogenesis.
Mariya N. Lun'kova +4 more
doaj +2 more sources
Assessing the causality between thyroid and breast neoplasms: A bidirectional Mendelian randomization study. [PDF]
Aim This study aimed to evaluate the association between thyroid neoplasms (TN) and the risk of developing breast neoplasms (BN) by assessing data on single nucleotide polymorphisms (SNPs) obtained from the Deutsches Krebsforschungszentrum (DKFZ) and ...
Li Z, Xia L, Li X, He H.
europepmc +2 more sources
INSM1 Expression in Breast Neoplasms with Neuroedocrine Features. [PDF]
According to the 2019 WHO classification of breast tumors, neuroendocrine neoplasms (NENs) are classified into well-differentiated NE tumors (NET) and poorly differentiated NE carcinomas (NEC), while other breast cancers (BCs) of special and no special ...
Metovic J +6 more
europepmc +2 more sources
Serum Levels of Irisin and Omentin-1 in Breast Neoplasms and Their Association with Tumor Histology. [PDF]
Breast cancer is associated with obesity, possibly due to direct effects of adipokines and myokines, such as omentin-1 and irisin. In this study, we aimed to evaluate omentin-1 and irisin levels in women with benign and/or malignant breast neoplasms vs ...
Panagiotou G +3 more
europepmc +2 more sources
Carcinosarcoma of breast – A chimera among breast neoplasms
Malignant phyllodes, along with ductal carcinoma, is known as metaplastic cancer of the breast. This tumor is additionally known as breast carcinosarcoma.
Vandana Tomey +3 more
doaj +3 more sources
Neuroendocrine Neoplasms of the Breast
Neuroendocrine differentiation in breast neoplasms has been a matter of discussion since the first description of a neuroendocrine neoplasm (NEN) in this site. In fact, NENs of the breast (Br-NENs) represent a less well-defined group of neoplasms than analogous entities in other organs, such as the lung and the gastroenteropancreatic tract.
Uccella, Silvia +3 more
openaire +3 more sources
The Correlation of Plasma 25-Hydroxyvitamin D Deficiency With Risk of Breast Neoplasms: A Systematic Review. [PDF]
Context Breast cancer has been considered as one of the most common types of cancer among the women worldwide, and patients with breast neoplasms have been reported with high prevalence of low serum 25-hydroxyvitamin D levels.
Shekarriz-Foumani R, Khodaie F.
europepmc +2 more sources

